The Future of Liver Cancer Care
A connected, clinician-led, continuously learning ecosystem for coordinated, high-quality liver cancer care.
Liver cancer care today is fragmented. Patients and clinicians face:
Manual, time-consuming coordination
Slow adoption of innovations
Decisions made in silos with data gaps
Delays that impact outcomes and costs
LORiMDT is a clinician-led digital ecosystem that unifies clinical evidence, imaging, labs, tumor board workflows, and real-world outcomes into one coordinated, continuously learning platform.
Core Pillars
Accessibility
World-class expertise—accessible from anywhere
Coordination
Seamless, integrated workflows across specialties
Adaptability
Evidence that evolves in real time
Continuous Learning
Every case strengthens the LORiMDT platform
Methodology
Integrate
Multidisciplinary data in one place
Analyze
Machine learning with MD clinical oversight
Orchestrate
Care recommendations and treatment plans
Learn
Continuous improvement with each case
Clinician-Led by Design
Our expert panel governs pathways, validates insights, and ensures clinical relevance at every step.
Talia B. Baker, MD, FACS
Talia B. Baker, MD, FACS is a nationally recognized transplant and liver cancer surgeon with over 20 years of leadership at leading academic institutions, including Northwestern University, the University of Chicago, and the University of Utah. An international thought leader in transplant oncology, she founded and chairs the American Society of Transplant Surgeons’ Transplant Oncology Task Force, helping establish standards for multidisciplinary care and patient selection. In 2024, Dr. Baker launched LORI – the Liver Oncology Reimagined Initiative, an AI-powered, EMR-integrated orchestration ecosystem designed to address systemic fragmentation, variation, and inequity in liver cancer care. LORI enables coordinated, evidence-adaptive decision-making across teams while generating real-world clinical evidence to accelerate translation of innovation into everyday patient care.
Dirk Slaker, MD
Dr. Slaker is a board-certified physician and visionary leader in clinical medicine with more than two decades of specialized experience in liver disease, transplant medicine, and the care of medically complex patients. His career spans both academic institutions and community practice settings, providing him with a comprehensive understanding of how liver disease presents, progresses, and is managed across diverse patient populations and healthcare systems. This broad perspective has positioned him as a trusted expert in tackling high-acuity liver disease challenges across varied care settings through innovative, patient-centered solutions that reshape how advanced liver disease is understood and treated. Known for his integrity, evidence-based practice, and unwavering commitment to patient advocacy, Dr. Slaker is dedicated to advancing reliable, accessible, and clinically sound solutions for individuals facing liver cancer.
Converting every case into actionable insight, every team into a learning system, and every patient into a measurable success.